Search - tctmd.com

Displaying 1 - 19 of 19

Sort: Relevancy | Date

Presentation CDM 2018

The Hope and Promise of Renal Denervation

Presenter: Michael A.Weber

October 12, 2018

Presentation TCT 2014

Noninvasive Renal Denervation Using Externally Delivered Focused Ultrasound: Early Experience Using Doppler-Based Imaging Tracking and Targeting for Treatment

Presenter: Michael Joner, Horst Sievert, Steven L. Almany, John A. Ormiston

September 16, 2014

Presentation TCT 2014

TCT 404: First Clinical Experience with Neurotropic Agents for Treatment of Sympathetic Hypertension

Presenter: Michael R. Jaff, Horst Sievert, Michael J. Rinaldi

September 14, 2014

Presentation TCT 2014

Extravascular Focused Ultrasound for Renal Denervation: Kona Medical Update

Presenter: Michael R. Jaff, Horst Sievert, Michael J. Rinaldi, John A. Ormiston

September 14, 2014

Presentation TCT 2014

TCT 406: Renal Artery Trauma Induced by Four Different Renal Denervation Systems: A Multimodality Intraarterial Imaging Study

Presenter: Deepak L. Bhatt, Michael A. Weber, William A. Gray, Antonios Karanasos

September 14, 2014

Presentation TCT 2014

Updates and Status of the Cordis Renlane Program

Presenter: Deepak L. Bhatt, Michael A. Weber, William A. Gray, Felix Mahfoud

September 14, 2014

Presentation TCT 2014

Updates and Status of the ReCor Paradise Program

Presenter: Deepak L. Bhatt, Michael A. Weber, William A. Gray, Thomas Zeller

September 14, 2014

Presentation TCT 2014

Updates and Status of the St. Jude EnligHTN Program

Presenter: Deepak L. Bhatt, Michael A. Weber, William A. Gray

September 14, 2014

Presentation TCT 2014

Updates and Status of the Boston Scientific Vessix Program

Presenter: Deepak L. Bhatt, Michael A. Weber, William A. Gray, Ajay J. Kirtane

September 14, 2014

Presentation TCT 2014

From SYMPLICITY HTN-1 to the Global SYMPLICITY Registry and Beyond: Updates from and Status of the SYMPLICITY Clinical Trial Program

Presenter: Deepak L. Bhatt, Michael A. Weber, William A. Gray, Michael Boehm

September 14, 2014

Presentation TCT 2014

TCT 405: SYMPLICITY HTN-3: Outcomes in the African-American and NonAfrican American Populations

Presenter: Deepak L. Bhatt, Michael A. Weber, William A. Gray, John Flack

September 14, 2014

Presentation TCT 2014

First Deep Dive into SYMPLICITY HTN-3: Primary Results and Updated Analyses

Presenter: Deepak L. Bhatt, Michael A. Weber, William A. Gray

September 14, 2014

Presentation TCT 2014

Current Status of Advanced Hypertension Treatment in the United States

Presenter: Ajay J. Kirtane, Felix Mahfoud, John A. Ormiston, Michael A. Weber

September 13, 2014

Presentation TCT 2014

Renal Nerve Microanatomy - The Foundation for RDN Technologies

Presenter: Juan F. Granada, Paul A. Sobotka, Farrell O. Mendelsohn, Michael Joner

September 13, 2014

Presentation

Why is there So Much Excitement Over Renal Denervation?

Presenter: Michael R. Jaff

December 01, 2013

Presentation TCT 2013

Noninvasive Evaluation of Resistant Hypertension: Two Case Examples

Presenter: Michael Jaff

October 31, 2013

Presentation TCT 2013

Veropaque, A Novel Contrast Formulation, Mitigates Contrast Induced Acute Kidney Injury

Presenter: Sangita Biswas, Elizabeth Rowe, Gerold Mosher, Lovella Insisienmay, Marlies Ozias, Michael Gralinski, Vernon Rowe

January 31, 2013

Presentation TCT 2012

TCT-9. Morphological Assessment of Renal Arteries After Radiofrequency Catheter-based Sympathetic Denervation in a Porcine Model

Presenter: Michael Joner

October 23, 2012

Presentation TCT 2012

Role of Renal Revascularization in 2012 and Predictions for the Future

Presenter: Michael Jaff

October 22, 2012

Advertisement

The Hope and Promise of Renal Denervation

Noninvasive Renal Denervation Using Externally Delivered Focused Ultrasound: Early Experience Using Doppler-Based Imaging Tracking and Targeting for Treatment

TCT 404: First Clinical Experience with Neurotropic Agents for Treatment of Sympathetic Hypertension

Extravascular Focused Ultrasound for Renal Denervation: Kona Medical Update

TCT 406: Renal Artery Trauma Induced by Four Different Renal Denervation Systems: A Multimodality Intraarterial Imaging Study

Updates and Status of the Cordis Renlane Program

Updates and Status of the ReCor Paradise Program

Updates and Status of the St. Jude EnligHTN Program

Updates and Status of the Boston Scientific Vessix Program

From SYMPLICITY HTN-1 to the Global SYMPLICITY Registry and Beyond: Updates from and Status of the SYMPLICITY Clinical Trial Program

TCT 405: SYMPLICITY HTN-3: Outcomes in the African-American and NonAfrican American Populations

First Deep Dive into SYMPLICITY HTN-3: Primary Results and Updated Analyses

Current Status of Advanced Hypertension Treatment in the United States

Renal Nerve Microanatomy - The Foundation for RDN Technologies

Why is there So Much Excitement Over Renal Denervation?

Noninvasive Evaluation of Resistant Hypertension: Two Case Examples

Veropaque, A Novel Contrast Formulation, Mitigates Contrast Induced Acute Kidney Injury

TCT-9. Morphological Assessment of Renal Arteries After Radiofrequency Catheter-based Sympathetic Denervation in a Porcine Model

Role of Renal Revascularization in 2012 and Predictions for the Future

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content